Amylyx Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $442k | 32k | 13.90 |
| 2025-03-31 | $1.6M | 463k | 3.54 |
| 2024-12-31 | $2.3M | 609k | 3.78 |
| 2024-09-30 | $1.9M | 575k | 3.24 |
| 2024-06-30 | $1.3M | 663k | 1.90 |
| 2024-03-31 | $2.7M | 915k | 3.00 |
| 2023-12-31 | $7.7M | 531k | 14.50 |
| 2023-09-30 | $2.9M | 160k | 18.31 |
| 2023-03-31 | $2.0M | 68k | 29.34 |
| 2022-12-31 | $4.3M | 116k | 36.95 |
| 2022-09-30 | $5.7M | 201k | 28.09 |